The impact of type 2 diabetes on mortality in end-stage renal disease patients differs between genders

Nephron - Clinical Practice

Volumn 112, Issue 4, 2009, Pages

  Karame A ^a,b   Labeeuw, M ^a,b   Trolliet, P ^a   Caillette Beaudoin, A ^c   Cahen, R ^a   Ecochard, R ^b,d   Galland, R ^c   Hallonet, P ^c   Pouteil Noble, C ^a,b   Villar, E ^a,e  

^a Nephrology and Renal Transplantation   (United States)

^b UNIVERSITÉ LYON 1   (France)

^c Lucien Hussel Hospital   (United States)

^d HOSPICES CIVILS DE LYON   (France)

^e CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Dialysis; End stage renal disease; Survival, gender; Type 2 diabetes mellitus

Indexed keywords

AGED; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DIABETIC PATIENT; DIALYSIS; FEMALE; FRANCE; HAZARD RATIO; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SEX DIFFERENCE;

EID: 67449113444     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000224794     Document Type: Article

References (33)

1. Ubink-Veltmaat LJ, Bilo HJG, Groenier KH, Houweling ST, Rischen RO, Meyboom-de Jong B: Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in the Netherlands (ZODIAC-1). Eur J Epidemiol 2003; 18: 793-800.
2. Gu K, Cowie CC, Harris MI: Mortality in adults with and without diabetes in a national cohort of the US population, 1971-1993. Diabetes Care 1998; 21: 1138-1145.
3. Salles GF, Bloch KV, Cardoso CR: Mortality and predictors of mortality in a cohort of Brazilian type 2 diabetic patients. Diabetes Care 2004; 27: 1299-1305.
4. van Dijk PC, Jager KJ, Stengel B, Gronhagen-Riska C, Feest TG, Briggs JD: Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). Kidney Int 2005; 67: 1489-1499.
5. Couchoud C, Stengel B, Jacquelinet C: REIN annual report 2005. Renal Epidemiology and Information Network and Agence de la Biomédecine. Nephrol Ther 2007; 3(suppl 1):S1-S82.
6. Sorensen VR, Mathiesen ER, Heaf J, Feldt-Rasmussen B: Improved survival rate in patients with diabetes and end-stage renal disease in Denmark. Diabetologia 2007; 50: 922-929.
7. Villar E, Chang SH, McDonald SP: Incidences, treatments, outcomes, and gender effect on survival in end-stage renal disease patients by diabetic status in Australia and New Zealand (1991-2005). Diabetes Care 2007; 30: 3070-3076.
8. US Renal Data System: USDRS 2006 Annual Data Report-Atlas of End-Stage Renal Disease in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006.
9. Jagger KJ, van Dijk PC, Dekker FW, Stengel B, Simpson K, Briggs JD: The epidemic of ageing in renal replacement therapy: an update on elderly patients and their outcomes. Clin Nephrol 2003; 60: 352-360.
10. Lutz W, Sanderson W, Scherbov S: The coming acceleration of global population ageing. Nature 2008; 451: 716-719.
11. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
12. Gaede P, Lund-Andersen H, Parving HH, Pedersen O: Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358: 580-591.
13. James WP, Rigby N, Leach R: Obesity and the metabolic syndrome: the stress on the society. Ann NY Acad Sci 2006; 1083: 1-10.
14. Hu G, Jousilahti P, Qiao Q, Katoh S, Tuomilehto J: Sex differences in cardiovascular and total mortality among diabetic and nondiabetic individuals with or without history of myocardial infarction. Diabetologia 2005; 48: 856-861.
15. Juutilanen A, Kortelainen S, Lehto S, Rönnemaa T, Pyörälä K, Laasko M: Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 2004; 27: 2898-2904.
16. Villar E, Remontet L, Labeeuw M, Ecochard R: Effects of age, sex and diabetes on excess death in end-stage renal failure. J Am Soc Nephrol 2007; 18: 2125-2134.
17. Trovato F, Heysen NB: A varied pattern of change of the sex differential in survival in the G7 countries. J Biosoc Sci 2006; 38: 391-401.
18. Villar E, Rabilloud M, Berthoux P, Vialtel P, Labeeuw M, Pouteil-Noble C: A multicentre study of registration on renal transplantation waiting list of the elderly and patients with type 2 diabetes. Nephrol Dial Transplant 2004; 19: 207-214.
19. Shoenfeld DA, Richter DJ: Nomograms for calculating the numbers of patients needed for a clinical trial with survival as an endpoint. Biometrics 1982; 38: 163-170.
20. Couchoud C, Stengel B, Landais P, Aldigier JC, de Cornelissen F, Dabot F, Maheut H, Joyeux V, Kessler M, Labeeuw M, Isnard H, Jacquelinet C: The renal epidemiology and information network (REIN): a new registry for end-stage renal disease. Nephrol Dial Transplant 2006; 21: 411-418.
21. Villar E, Frimat L, Ecochard R, Labeeuw M: Specificities of the methodology of survival analysis in dialysis patients. Nephrol Ther 2008; 4: 553-561.
22. Therneau TM, Grambsch PM: Testing proportional hazards; in Grambsch P, Mayo Foundation (eds): Modeling Survival Data: Extending the Cox Model. Rochester, Springer, 2000, pp 127-152.
23. Grambsch PM, Therneau TM: Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994; 81: 515-526.
24. Lee WL, Cheung AM, Cape D, Zinman B: Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care 2000; 23: 962-968.
25. McFadden E, Luben R, Wareham N, Bingham S, Khaw KT: Occupational social class, educational level, smoking and body mass index, and cause-specific mortality in men and women: a prospective study in the European Prospective Investigation of Cancer and Nutrition in Norfolk (EPIC-Norfolk) cohort. Eur J Epidemiol 2008; 23: 449-458.
26. de Mutsert R, Snidjer MB, van der Sman-de Beer F, Seidell JC, Boeschoten EW, Krediet RT, Dekker JM, Vandenbroucke JP, Dekker FW, for the Netherlands Cooperative Study on the Adequacy Dialysis-2 (NECOSAD) Study Group: Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol 2007; 18: 967-974.
27. Williams ME, Lacson EJ, Teng M, Ofsthun N, Lazarus JM: Hemodialyzed type I and type II diabetic patients in the US: characteristics, glycemic control, and survival. Kidney Int 2006; 70: 1503-1510.
28. de Mutsert RD, Grootendorst DC, Axelsson J, Boeschoten EW, Krediet RT, Dekker FW, the NECOSAD Study Group: Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients. Nephrol Dial Transplant 2008; 23: 2957-2964.
29. Stenkivel P, Barany P, Chung SH, Lindholm B, Heimbürger O: A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients. Nephrol Dial Transplant 2002; 17: 1266-1274.
30. Teede HJ: Sex hormones and the cardiovascular system: effects on arterial function in women. Clin Exp Pharmacol Physiol 2007; 34: 672-676.
31. Norris K, Nissesson AR: Race, gender, and socioeconomic disparities in CKD in the United States. J Am Soc Nephrol 2008; 19: 1261-1270.
32. Cukor D, Peterson RA, Cohen SD, Kimmel PL: Depression in end-stage renal disease hemodialysis patients. Nat Clin Pract Nephrol 2006; 2: 678-687.
33. Depmer T, Daugirdas J, Greene T, Allon M, Beck G, Chumlea C, Delmez J, Gotch F, Kusek J, Levin N, Macin E, Milford E, Owen W, Star R, Toto R, Eknoyan G: Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int 2004; 66: 1386-1394.